Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TAF5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IL12A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIM8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL42 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC50A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CASC7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRDX3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MKX - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD44 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TOMM70 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF155 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SHROOM3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TM9SF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BUB3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP3CB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RND3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NMD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL6R - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CRTAP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on